VISION STATEMENT
-
INDIA TO BE AMONG THE
"TOP 5" PREFFERED SOURCES IN EACH PRODUCT FAMILY OF
MEDICAL DEVICES
-
INDIAN MEDICAL DEVICE
REGULATORY AUTHORITY, A CENTRE FOR EXCELLENCE,
ASSISTING THE MEDICAL DEVICE INDUSTRY TO PRODUCE
PRODUCTS WITH ADEQUATE AND APPROPRIATE CONTROLS AND
SYSTEMS FOR ENSURING PATIENT SAFETY
|
Current Status -
Regulations
-
18-20
Medical Devices under Drugs & Cosmetics Act 1940
-
Treatment similar to Drugs/Medicines
-
Controlled & Inspected
by
-
License Raj ,undergoing review
-
Limited Knowledge/Competencies
-
Inspections, not standardized audits
-
Lack
of acceptance of Risk based Assessment
-
New
products/Technologies - Non existent product
Standards
|
VISION - Role of the
Industry
-
Accountable to the
Public through a Regulator
-
Well run & managed
-
Meet the legal
obligations
-
Delivery of Affordable
low cost products
|
Current Status -
Industry
-
Majority Exporting units
comply with ISO13485 and Certificate/Registration
with GHTF countries
-
Moving up the Value
Chain
-
Moving up the Quality &
Technology Ladder
-
"Top 5" Preferred Source
Status achieved in: p
1) Syringes
2) Needles
3) I.V. Cannulas /Catheters
4) Contraceptives
5) Surgical Blades
6) Gloves
|
VISION - Role of
Regulator
-
Work with Industry in
transparent manner
-
Supervise Directly
Through Accredited agencies
-
Aim to promote public
trust in Indian Industry
-
Provide Guidance &
Advice
- to meet legal
obligations
- safety of consumers
|
SWOT ANALYSIS -
Industry
|
Strengths
Cost Competitiveness,
Mass production, Economies of scale, Trainable
large Labor Pool, Technology Access - no
conflicting national interest. Strong in
Mechanical, Software, Biotechnology Engineering
Respect for System & Document compliance. |
|
Weakness
Low R&D base, Reliance
on High Cost imported inputs.
High Cost Multiple
Taxes. Limited products regulated.
Quality perception low
middle end low- end. |
|
Opportunity
Value for money
competitiveness, high growth sales in global
markets. |
|
Threat
Regulations limiting
market access if used as Protectionist Non Tariff
Barrier |
|
|
SWOT ANALYSIS -
Regulator
Strengths
Reliance on Factory Inspections for domestic producers
Access to pool of inspectors well versed with GMP
w.r.t. Pharmaceutical Industry, Strong legal framework
Weakness
Limited/no knowledge of diverse nature of
manufacturing technologies
Limited knowledge of regulating non sterile medical
devices
Regulatory framework not developed , structured for
medical devices
Lack of accredited Testing facilities for product
conformity verification
No inspections for overseas manufacturers,
lacks transparency & guidance
Opportunities
Up
gradation of Regulatory framework on GHTF guidelines
Facilitate Respect & Growth Of Indian industry
Threats
Non
manufacturer Devices from Regulated may harm patients
Non Recognition by overseas regulators |
If Things go wrong.......
-
Regulations to provide non ambiguous legal
requirements & guidance on best practices
-
Reliance on preventing problems
-
Evaluation of Risk & Hazard by MDR for suitable
corrective action & preventive (CAPA)
-
Reasonable time for addressing issues and
implementing CAPA
-
Regulator to have powers for putting things right
-
Minimal/No reliance of judiciary and legal criminal
action on registered units
-
Reliance of Judiciary/ Police and criminal action
only on non registered units.
|
Path for the Industry
- manufacturing &
testing facilities
- management competencies
- quality management systems
- Get ISO 13485
certification from internationally accredited
organizations
- Get registration and
certification from a GHTF member country
- Self
regulation/Dialog with MOH to assist in building
regulatory framework
|
Pitfalls & Avoidance
-
Lack of trust and dialog
-
Lack of time bound
response to queries
-
Reliance on Tests,
inspections, arbitrary controls
-
Draconian punitive
action
-
Unreasonable
expectations
-
Lack of clarity of
superseded rules/requirements and standards
-
Conformity assessment
organizations acting as consultants / trainers to
same assesses
|
|
Path for the Regulator
-
Improve transparency & dialog
-
Involve Industry in creating a
mutually acceptable Regulatory Framework &
Infrastructure.
-
Ensure timely response to
guidance/ advice sought on clarifications of
compliances
-
Constitute expert committees on
various aspects
-
Define milestones for phased
creation of a regulatory infrastructure &
implementation p
-
Recognize risk based
classification of devices and need for variation in
regulatory controls, premarket registration &
approvals proportionate to these risks.
-
Delegate supervision of
conformity assessment to internationally accredited
organizations with proven competencies
|
|